| Date | Title | Description |
| 21.06.2023 | Sequana Medical announces additional data on safety, quality... | Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), a pioneer in the ... |
| 16.06.2023 | Sequana Medical wins Best Technology Award for alfapump® at ... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the... |
| 25.04.2023 | Sequana Medical successfully raises EUR 15.78 million in an ... | Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"... |
| 09.02.2023 | Sequana Medical announces 2022 Full Year Results and 2023 Ou... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the... |
| 08.02.2023 | Sequana Medical announces the successful completion of pre-c... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the... |
| 05.02.2023 | JenaValve Appoints Dan Dearen to Board of Directors | JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve ... |
| 01.02.2023 | Sequana Medical announces grant of additional DSR® patent in... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the... |
| 15.11.2022 | Sequana Medical announces positive top-line results from SAH... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the... |
| 01.11.2022 | Sonendo® Announces Health Canada Regulatory Approval for Nex... | Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® Sys... |
| 25.10.2022 | Sequana Medical announces positive top-line results from the... | Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), a pioneer in the ... |
| 19.10.2022 | Sonendo, Inc. to Report Third Quarter 2022 Financial Results... | Sonendo, Inc. (“Sonendo”) (NYSE: SONX), a leading dental technology company and developer of the Gen... |
| 18.10.2022 | Sonendo® Announces Next Generation GentleWave® G4 System | Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® Sys... |
| 23.09.2022 | Sonendo, Inc. Announces $63 Million Private Placement | Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® Sys... |
| 14.09.2022 | JenaValve Completes Enrollment in the ALIGN-AR IDE Clinical ... | JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve ... |
| 08.09.2022 | Sequana Medical announces H1 2022 results and provides busin... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the... |
| 31.08.2022 | JenaValve Raises $100 Million to Advance Trilogy TAVR Soluti... | JenaValve Technology, Inc. (“JenaValve or the “Company”), developer and manufacturer of differentiat... |
| 25.08.2022 | Alexandra Clyde appointed to Sequana Medical Board of Direct... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the... |
| 10.08.2022 | Sonendo, Inc. Reports Second Quarter 2022 Financial Results | Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® Syst... |
| 20.07.2022 | Sequana Medical secures EUR 10 million loan facility with Kr... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the... |
| 19.07.2022 | Sequana Medical completes enrollment in Phase 2a SAHARA I DS... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the... |
| 05.07.2022 | Sonendo, Inc. Welcomes Joanne Lindberg as Vice President of ... | Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® Sys... |
| 28.06.2022 | Results of First Commercial Trilogy Heart Valve System Impla... | JenaValve Technology, Inc. (“JenaValve” or the “Company”), developer and manufacturer of differentia... |
| 17.06.2022 | Sonendo, Inc. Announces Executive Management Team Changes | Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® Sys... |
| 17.05.2022 | JenaValve Appoints Kari Moore as Chief Financial Officer | JenaValve Technology, Inc. (“JenaValveor the “Company”), developer and manufacturer of differentiate... |
| 10.05.2022 | Sonendo, Inc. Reports First Quarter 2022 Financial Results | Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® Syst... |
| 20.04.2022 | Sonendo Announces Launch of CleanFlow Technology to Improve... | Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® Sys... |
| 05.04.2022 | Sequana Medical announces the completion of alfapump® implan... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical”), an innovator in ... |
| 23.03.2022 | Sonendo Inc. Reports Fourth Quarter 2021 Financial Results a... | Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® Syst... |
| 15.03.2022 | Sonendo, Inc. Hits New Milestone of 800,000 GentleWave® Proc... | Sonendo, Inc. (NYSE: SONX), a dental technology company and creator of the GentleWave System for les... |
| 10.03.2022 | Sequana Medical announces new Share Capital Amount and New N... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), an innovator in ... |
| 02.03.2022 | Sonendo, Inc. to Report Fourth Quarter and Full Year 2021 Fi... | Sonendo, Inc. (“Sonendo”) (NYSE: SONX), a leading dental technology company and developer of the Gen... |
| 14.02.2022 | Sequana Medical receives certification under MDR, the new Eu... | Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in t... |
| 18.01.2022 | JenaValve Announces Strategic Investment and Licensing Agree... | JenaValve Technology, Inc. (“JenaValve” or the “Company”), developer and manufacturer of differentia... |
| 14.01.2022 | Sonendo, Inc. Announces Preliminary Revenue Results for the ... | Sonendo, Inc. (“Sonendo”) (NYSE: SONX), a leading dental technology company and developer of the Gen... |
| 09.12.2021 | Sonendo Inc. Reports Third Quarter 2021 Financial Results an... | Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® Syst... |
| 07.12.2021 | Sequana Medical announces positive interim results of SAHARA... | Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or Sequana Medical), an innovator in the... |
| 06.12.2021 | Sequana Medical announces the completion of patient enrolmen... | Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in t... |
| 10.11.2021 | Sonendo's GentleWave Surpasses 700,000 Treatments, Solidifyi... | Sonendo, Inc., (NYSE: SONX) a leading dental technology company and developer of the GentleWave® Sys... |
| 28.10.2021 | Sonendo, Inc. Announces Pricing of Initial Public Offering | Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, today an... |
| 25.10.2021 | Sonendo, Inc. Announces Launch of Initial Public Offering | Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® Syst... |
| 18.10.2021 | Immunocore and Medison Pharma Partner for Future Commerciali... | Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel ... |
| 14.10.2021 | JenaValve Announces First European Commercial Implants with ... | JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve ... |
| 08.10.2021 | Sonendo®, Inc. Announces Filing of Registration Statement fo... | Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, today an... |
| 05.10.2021 | Sonendo® Acquires Portfolio of Novel Dental Procedure Techno... | On October 5, 2021, Sonendo, Inc., announced its acquisition of all assets of Israeli dental company... |
| 04.10.2021 | Sequana Medical announces FDA approval to expand patient enr... | Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diure... |
| 16.09.2021 | Repligen Announces Agreement to Acquire Avitide Inc. | Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology lead... |
| 08.09.2021 | Immunocore Announces UKs Medicines and Healthcare Products ... | Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel ... |
| 02.09.2021 | Sequana Medical announces H1 2021 results and provides busin... | Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diure... |
| 31.08.2021 | Sequana Medical appoints Jackie Fielding, former Medtronic V... | Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diure... |
| 24.08.2021 | Food and Drug Administration and European Medicines Agency a... | Immunocore Holdings Plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the developmen... |
| 16.08.2021 | JenaValve Receives IDE Approval to Initiate The ALIGN-AR Piv... | JenaValve Technology, Inc., developer, and manufacturer of differentiated transcatheter aortic valve... |
| 11.08.2021 | Immunocore Reports Second Quarter 2021 Financial Results and... | Immunocore Holdings plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the developmen... |
| 06.07.2021 | Sequana Medicals results from RED DESERT alfapump DSR® stud... | Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in t... |
| 01.07.2021 | Sequana Medical announces positive results from second inter... | Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in t... |
| 04.06.2021 | Immunocore presents clinical data further characterizing the... | Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel ... |
| 01.06.2021 | Sequana Medical announces first patient enrolled in SAHARA D... | Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the treatment of diuretic-resistant f... |
| 25.05.2021 | JenaValve Technology Receives CE Mark for its TrilogyTM TAVI... | JenaValve Technology, Inc., developer, and manufacturer of differentiated transcatheter aortic valve... |
| 20.05.2021 | Axonics® Receives FDA Approval Further Expanding MRI Labelin... | Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commerciali... |
| 18.05.2021 | Axonics® Announces CE Mark Approval for Implantable Sacral N... | Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commerciali... |
| 18.05.2021 | Immunocore announces dosing of first patient with ImmTAV® bi... | Immunocore Holdings Plc (Nasdaq: IMCR) (or the “Company”), a pioneering, clinical‐stage T cell recep... |
| 14.05.2021 | Axonics® Announces Closing of Public Stock Offering and Full... | Axonics, Inc. (Nasdaq: AXNX), (“Axonics”), a global medical technology company that is developing an... |
| 12.05.2021 | Immunocore Reports First Quarter 2021 Financial Results | Immunocore Holdings Plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the developmen... |
| 11.05.2021 | Sequana Medical announces strong top-line results from RED D... | Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the treatment of diuretic-resistant f... |
| 11.05.2021 | Axonics® Announces Upsize and Pricing of Public Offering of ... | Axonics, Inc. (Nasdaq: AXNX) (“Axonics”), a global medical technology company that has developed and... |
| 06.05.2021 | Axonics® Reports First Quarter 2021 Financial Results | Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commerciali... |
| 12.04.2021 | Immunocore presents phase 3 data comparing tebentafusp with ... | Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel ... |
| 25.03.2021 | Immunocore Provides Business Update and Reports Full Year 20... | Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel ... |
| 17.03.2021 | Sequana Medical announces 2020 Full Year Results and 2021 Ou... | Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diure... |
| 02.03.2021 | Axonics® Announces Strategic Alliance for the Manufacture of... | Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a global medical technology company that has d... |
| 01.03.2021 | Oxular raises $37 million | Oxular Limited (“Oxular”), a leading retinal therapeutics development company, today announced that ... |
| 25.02.2021 | Axonics® Expands into Stress Urinary Incontinence with the A... | Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has develope... |
| 25.02.2021 | Axonics® Reports Fourth Quarter and Fiscal Year 2020 Results... | Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has develope... |
| 19.02.2021 | Immunocores tebentafusp granted Breakthrough Therapy Design... | Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel ... |
| 09.02.2021 | Immunocore Announces Closing of $312.1 Million Financing | Immunocore Holdings plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the developmen... |
| 09.02.2021 | Immunocore Announces Closing of $312.1 Million Aggregate Fin... | Immunocore Holdings plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the developmen... |
| 08.02.2021 | Dr. Jatinder Kapur appointed as VP of Quality | Oxular Limited (“Oxular”), a leading retinal therapeutics development company, today announces that ... |
| 05.02.2021 | Immunocore Announces Pricing of Upsized Initial Public Offer... | Immunocore Holdings plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the developmen... |
| 04.02.2021 | Sequana Medical announces granting of key alfapump DSR® pate... | Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the treatment of diuretic-resistant f... |
| 25.01.2021 | Axonics® Reports Preliminary Fourth Quarter and Fiscal Year ... | Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has develope... |
| 11.01.2021 | Immunocore announces closing of $75.0 Million Series C round | Immunocore, a late-stage biotechnology company pioneering the development of a novel class of T cell... |
| 16.12.2020 | Sonendo® Launches 500K Club Charitable Initiative | Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, announce... |
| 08.12.2020 | Sonendo® Reaches 500,000 Patients Treated Milestone with the... | Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, today an... |
| 03.12.2020 | Immunocore presents Phase 2 tebentafusp clinical results at ... | Immunocore (or the “Company”), a late-stage biotechnology company pioneering the development of a no... |
| 23.11.2020 | Immunocores tebentafusp demonstrates superior overall survi... | Immunocore (the “Company”), a late-stage biotechnology company pioneering the development of a novel... |
| 19.11.2020 | Sequana Medical announces positive interim data from North A... | Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in l... |
| 03.11.2020 | Genkyotex announces the closing of the acquisition by Callid... | Genkyotex (Euronext Paris & Brussels: FR0013399474 – GKTX), a biopharmaceutical company and the ... |
| 22.10.2020 | Sequana Medical announces strong interim results from RED DE... | Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in l... |
| 20.10.2020 | Axonics® Launches ARTISTRY Study to Collect and Analyze Real... | Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has develope... |
| 20.10.2020 | Genkyotexs setanaxib granted Orphan Drug Designation by the... | Genkyotex (Euronext Paris & Brussels: FR0013399474 – GKTX), a biopharmaceutical company and lead... |
| 08.10.2020 | X4 Pharmaceuticals Announces Fast Track Designation Granted ... | X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapie... |
| 07.10.2020 | Axonics® CEO Raymond W. Cohen Named Ernst & Young Entrep... | Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has develope... |
| 05.10.2020 | Axonics® Announces Survey Results of Patients Treated with t... | Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has develope... |
| 24.09.2020 | Axonics® Provides Update on Inter Partes Review Proceedings | Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has develope... |
| 21.09.2020 | Axonics® Receives Health Canada Approval of Next Generation ... | Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has develope... |
| 17.09.2020 | Genkyotex announces first-half 2020 results and business upd... | Genkyotex (Euronext Paris & Brussels: FR0013399474 – GKTX), a biopharmaceutical company and lead... |
| 16.09.2020 | Axonics® CEO Raymond W. Cohen Named Ernst & Young Entrep... | Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has develope... |
| 14.09.2020 | Genkyotex announces the enrollment of the 1st patient in the... | Genkyotex (Euronext Paris & Brussels: FR0013399474 – GKTX), a biopharmaceutical company and lead... |
| 10.09.2020 | Axonics® Reports 2-Year Clinical Results from ARTISAN-SNM Pi... | Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has develope... |
| 08.09.2020 | NICE Recommends Axonics® r-SNM System for Treating Overactiv... | Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has develope... |
| 03.09.2020 | Sequana Medical announces H1 2020 results and provides busin... | Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), an innovator in ... |